Hong Kong, China vs Mongolia: New cases tested for RR-/MDR-TB
Hong Kong, China
96.0%
in 2024
Mongolia
96.0%
in 2024
Hong Kong, China rank
67th
Mongolia rank
67th
New cases tested for RR-/MDR-TB over time
- Hong Kong, China
- Mongolia
How they compare
Hong Kong, China currently reports 96.0% against 96.0% in Mongolia, a difference of 0.0%.
The two have swapped places 3 times across 18 shared years of data; in 2005 it was Hong Kong, China ahead.
Hong Kong, China ranks 67th and Mongolia ranks 67th of 192 countries.
Across the 3 decades both report, Hong Kong, China averaged higher in 2 and Mongolia in 1.
Head to head by decade
| Decade | Hong Kong, China | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.0% | 2.8% | 78.2% | Hong Kong, China |
| 2010s | 87.6% | 51.7% | 35.9% | Hong Kong, China |
| 2020s | 95.6% | 98.8% | 3.2% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Hong Kong, China or Mongolia?
- Hong Kong, China, at 96.0% against 96.0% in Mongolia as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Hong Kong, China and Mongolia?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Mongolia?
- 18 years are reported by both, from 2005 to 2024.
- How do Hong Kong, China and Mongolia rank globally for new cases tested for rr-/mdr-tb?
- Hong Kong, China ranks 67th and Mongolia ranks 67th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.